Elutia celebrates first year – 06.09.2024

Company thanks stakeholders and employees for a year of remarkable growth and performance

SILVER SPRING, Md., Sept. 6, 2024 (GLOBE NEWSWIRE) — Elutia Inc. (Nasdaq: ELUT) (“Elutia”), a pioneer in drug-eluting biomatrix products, celebrates its one-year anniversary and the team that made it possible. On September 6, 2023, as part of a strategic shift to drug-eluting biologics, the company changed its name to Elutia Inc. and established a mission of “Humanizing Medicine so Patients can Thrive without Compromise.” The following day, the company began trading on Nasdaq under the new ticker symbol “ELUT.”

In its first year as Elutia, the company achieved several key milestones and experienced impressive organic growth, including: